SME

IPO ·

NSE SME

Pramodini Medicare Ltd

Listed

Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments.

Issue details

Price band

₹110 – ₹118

Face value

₹10

Lot size

1,200 shares

Minimum investment

₹2,83,200

Issue size

₹69.04 Cr

Fresh issue

₹59.17 Cr

Offer for sale

₹5.90 Cr

Issue type

Book Built

Exchange

NSE SME

Key dates

Opens

12 Aug 2026

Closes

14 Aug 2026

UPI mandate cut-off

5:00 PM on 14 Aug 2026

Allotment

17 Aug 2026

Refunds

18 Aug 2026

Shares in demat

18 Aug 2026

Listing

19 Aug 2026

Subscription and listing

Subscription

3.26x

Listing price

₹120

Registrar

Purva Sharegistry (India) Pvt Ltd

Lead manager

Smart Horizon Capital Advisors

Subscription by category

Total

3.26x

Total applications

3,638

Anchor investors

Amount raised

₹16.06 Cr

Bid date

11 Aug 2026

50% lock-in ends

16 Sep 2026

Rest lock-in ends

15 Nov 2026

Listing day

Issue price

₹118

Open

₹120.00

High

₹125.55

Low

₹114.00

Day close

₹121.65

Listing gain at open

+1.69%

Issue structure

Shares reserved per category and share of the total issue

QIB

25,32,000

43.27%

Anchor Investor

13,60,800

23.26%

QIB (Ex. Anchor)

11,71,200

20.02%

NII

9,60,000

16.41%

bNII > ₹10L

6,39,600

10.93%

sNII < ₹10L

3,20,400

5.48%

Retail

20,23,200

34.58%

Market Maker

3,36,000

5.74%

Total

58,51,200

100.00%

Finaccle’s quick read

Apply

FY26 income up 64%, PAT up 56%, ROE 39.08%, D/E 0.34, post-issue P/E 14.97x.

A rules-based screen of growth, margins, debt and valuation, built from the offer document and data on Chittorgarh.com. It is for information only and is not investment advice or a recommendation to buy or sell. Read the RHP and speak to a SEBI-registered adviser before you apply.

About the company

Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments. The company provides services to public hospitals, private hospitals, public sector undertakings (PSUs), medical colleges, and private diagnostic centres across tier I, II, and III cities.

Founded

2000

2000

Promoters

Chalasani Kuldeep Kumar, Chalasani Kavitha, Chalasani Durga Aashritha, Chalasani Lalithakumar, Sri Ram Medicare Pvt.Ltd

Chalasani Kuldeep Kumar, Chalasani Kavitha, Chalasani Durga Aashritha, Chalasani Lalithakumar, Sri Ram Medicare Pvt.Ltd

Promoter holding

85.71% pre-issue; 62.64% post-issue

85.71% pre-issue; 62.64% post-issue

Financial performance

Restated figures in ₹ crore, latest period first

₹ crore, latest first. Full table on desktop.

Period

Total income

Income

EBITDA

PAT

Net worth

Borrowings

Debt

Assets

FY26

FY26

63.38

63.38

30.90

17.38

17.38

53.15

17.85

17.85

93.62

FY25

FY25

38.55

38.55

20.97

11.14

11.14

35.77

10.81

10.81

56.45

FY24

FY24

35.79

35.79

15.53

7.14

7.14

24.75

11.96

11.96

48.78

ROE

39.08%

ROCE

34.66%

Debt / equity

0.34

PAT margin

27.90%

P/E post issue

14.97

Market cap

₹260.14 Cr

Use of IPO money

Funding of capital expenditure for purchase of Medical Equipments towards Existing and Proposed Diagnostic Centres

₹45.15 Cr

General corporate purposes and unidentified inorganic acquisition

₹10.76 Cr

Issue Expenses

₹7.90 Cr

Strengths

✓

: Establishing a strategic presence across various states of India

✓

Strengthening its network through diversified business models

✓

Revenue up 64% in FY26 to ₹63.38 Cr

✓

PAT up 56% in FY26 to ₹17.38 Cr

✓

PAT margin of 27.90%

Risks to watch

!

SME platform: large lot size and thinner trading liquidity

Planning to take your own company public?

Every listing on this page started with a growing business that got its numbers, governance and paperwork ready for investors. If you are a promoter weighing an SME or main board IPO, we can tell you where you stand and what it will take.

Talk to our IPO Advisory team for readiness planning, or our IPO Consultancy team to run the listing end to end.

Last updated:

Information is compiled from exchange notices and the company’s offer document. It is for general information only and is not investment advice or a recommendation to apply. Read the prospectus before investing.